Population
Children and adults with dilated cardiomyopathy
Design
Review
Authors
Loading...
Informs carrier screening for hereditary DCM families; extends mutation-function links but leaves targeted therapy evidence open.
Identifying causative mutations in dilated cardiomyopathy enables disease prevention through carrier screening, prenatal testing, and potential targeted therapies.
Parvari et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: